OPTH
Optimi Health Corp
OPTH
Closed
$4.49
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. With its vertically integrated approach, the Company owns and operates two purpose built 10,000-square-foot licensed production sites in Princeton, British Columbia and holds a Drug Establishment Licence (DEL), as issued by Health Canada. Additionally, it holds a Dealer’s Licence under Canada’s Narcotic Control Regulations, allowing the Company to possess, produce, assemble, sell and deliver psilocybin and other psychedelic substances within the regulated framework set forth by Health Canada.
Key stats
Open
$4.65
Volume
13.90K
Market cap
$26.32M
Prev. close
$4.49
Impl / hst vl
-
Open interest
$0.00
$4.42
Day’s Range
$4.67
$4.00
52W Range
$6.20
Valuation
55
Valuation score
Fairly Valued
P/E
-
P/S
156.46
P/B
2.13
Current ratio
1.73
Debt / Equity
0.29
ROE
-63.57%
Gross margin
47.52%
Income growth
51.04%
FCF growth
733.98
Analysts estimates
Avg. price target
$10.55
The top 3 analysts forecasts that 12-month price may increase by 134.97%, with a low of $10.45 and a high of $10.86
$10.45
Low
$10.55
Avg
$10.86
High
Current price
Earnings
Q2 ‘26 revenue
$98.37K
Q2 ‘26 net income
-$1.69M
Revenue
Net income
Previous EPS
-$0.69
Estimate EPS
-$0.29
Actual EPS
Estimate EPS
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply